These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 22687760)

  • 1. Cell culture attenuation eliminates rMd5ΔMeq-induced bursal and thymic atrophy and renders the mutant virus as an effective and safe vaccine against Marek's disease.
    Lee LF; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
    Vaccine; 2012 Jul; 30(34):5151-8. PubMed ID: 22687760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
    Lee LF; Kreager K; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
    Avian Dis; 2013 Jun; 57(2 Suppl):491-7. PubMed ID: 23901766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
    Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
    Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
    Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
    Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV.
    Lee LF; Lupiani B; Silva RF; Kung HJ; Reddy SM
    Vaccine; 2008 Mar; 26(15):1887-92. PubMed ID: 18313812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of a recombinant Marek's disease virus lacking the meq oncogene and evaluation on its immune efficacy against Marek's disease virus.
    Sun P; Cui N; Liu L; Su S; Cheng Z; Chen R; Li Y; Cui Z
    Poult Sci; 2020 Apr; 99(4):1939-1945. PubMed ID: 32241474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant field strain of Marek's disease (MD) virus with reticuloendotheliosis virus long terminal repeat insert lacking the meq gene as a vaccine against MD.
    Su S; Cui N; Zhou Y; Chen Z; Li Y; Ding J; Wang Y; Duan L; Cui Z
    Vaccine; 2015 Jan; 33(5):596-603. PubMed ID: 25562789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of MEQ-deleted MDV vaccine candidates to adversely affect lymphoid organs and chicken weight gain.
    Dunn JR; Silva RF
    Avian Dis; 2012 Sep; 56(3):494-500. PubMed ID: 23050465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling in rMd5- and rMd5deltameq-infected chickens.
    Xu M; Zhang H; Lee L; Gao H; Sharif S; Silva RF; Heidari M
    Avian Dis; 2011 Sep; 55(3):358-67. PubMed ID: 22017031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
    Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
    Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective immunity of a meq-deleted Marek's disease virus against very virulent virus challenge in chickens].
    Su S; Li Y; Sun A; Zhao P; Ding J; Zhu H; Cui Z
    Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):380-6. PubMed ID: 20499644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
    Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
    Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.
    Calnek BW; Harris RW; Buscaglia C; Schat KA; Lucio B
    Avian Dis; 1998; 42(1):124-32. PubMed ID: 9533089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully Attenuated
    Sun A; Zhao X; Zhu X; Kong Z; Liao Y; Teng M; Yao Y; Luo J; Nair V; Zhuang G; Zhang G
    Microbiol Spectr; 2022 Dec; 10(6):e0287122. PubMed ID: 36350141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
    Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
    Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of a recombinant Marek's disease virus in vivo through expression of the Marek's EcoRI-Q (Meq)-encoded oncoprotein: characterization of an rMd5-based mutant expressing the Meq of strain RB-1B.
    Kumar P; Dong H; Lenihan D; Gaddamanugu S; Katneni U; Shaikh S; Tavlarides-Hontz P; Reddy SM; Peters W; Parcells MS
    Avian Dis; 2012 Jun; 56(2):328-40. PubMed ID: 22856190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of a UL5 helicase-primase subunit point mutation eliminates bursal-thymic atrophy of Marek's disease virus ∆Meq recombinant virus but reduces vaccinal protection.
    Hildebrandt E; Dunn JR; Cheng HH
    Avian Pathol; 2015; 44(4):254-8. PubMed ID: 25968878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
    Witter RL; Kreager KS
    Avian Dis; 2004 Dec; 48(4):768-82. PubMed ID: 15666858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene.
    Conradie AM; Bertzbach LD; Bhandari N; Parcells M; Kaufer BB
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.